Postdoctoral Fellow – Cancer Drug Resistance: Join us in the pursuit of improving human health and advancing our understanding of life on Earth. The Wellcome Sanger Institute in Hinxton, Cambridgeshire, is offering a full-time, 3-year fixed-term position for a highly-motivated Postdoctoral Research Fellow. The focus of this role is to investigate genetic mechanisms of drug resistance in lung cancer using state-of-the-art CRISPR/Cas9-based screening technologies. By employing gene editing techniques, coupled with single-cell transcriptomics, the Fellow will contribute to deepening our understanding of cancer drug resistance mechanisms and developing novel therapeutic strategies.
Designation: Postdoctoral Fellow
Research Area: Cancer Drug Resistance
Location: Hinxton, Cambridgeshire
Eligibility/Qualification:
- PhD in a biological science.
- Proven track record of scientific productivity.
- Experience in mammalian cell culture, single-cell RNA sequencing, and molecular biology techniques (PCR, cloning).
- Proficiency in preparing libraries for next-generation sequencing.
- Strong computer literacy.
- Effective teamwork and communication skills.
- Ability to work independently, adapt to changing priorities, and maintain high scientific standards.
Job Description: The Postdoctoral Research Fellow will:
- Execute large-scale screens and single-cell sequencing experiments.
- Analyze data and present findings internally and externally.
- Write high-quality publications.
- Collaborate with a multidisciplinary team.
- Investigate genetic mechanisms of drug resistance in lung cancer using CRISPR/Cas9-based technologies.
How to Apply: Interested candidates should submit their CV and a cover letter outlining their suitability for the role to Dr. Matt Coelho (matthew.coelho@sanger.ac.uk). The application deadline is 6th March 2024.
Last Date for Apply: 6th March 2024
Additional Information:
- Salary: £38,000 – £49,156 (dependent on skills and experience)
- Contract Duration: 3 years
- Contact: Dr. Matt Coelho (matthew.coelho@sanger.ac.uk) for further information.